Burzynski Research Institute, Inc.
BZYR · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.87 | -0.06 | 0.98 | 0.21 |
| FCF Yield | -5.10% | -13.28% | -5.13% | -8.24% |
| EV / EBITDA | -5.50 | 0.00 | -5.31 | -4.03 |
| Quality | ||||
| ROIC | 3,329.27% | 5,315.57% | 6,668.42% | -80,902.49% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.28 | 0.39 | 0.27 | 0.33 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 25.82% | -109.92% | 23.25% | 17.57% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |